**Core Concept**
Hormone replacement therapy (HRT) involves administering hormones to alleviate symptoms associated with menopause or andropause. This therapy can be systemic, delivering hormones throughout the body, or local, targeting specific areas. The primary goal of HRT is to restore hormone levels to pre-menopausal or pre-andropausal states.

**Why the Correct Answer is Right**
HRT is contraindicated in conditions where there is an increased risk of thromboembolic events, such as deep vein thrombosis (DVT) or pulmonary embolism (PE). This is because estrogen therapy can increase the levels of clotting factors in the blood, thereby increasing the risk of thrombosis. Additionally, HRT is contraindicated in patients with a history of breast cancer, as estrogen can stimulate the growth of breast cancer cells. Patients with undiagnosed vaginal bleeding should also avoid HRT, as it can mask the symptoms of underlying conditions such as endometrial cancer.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not listed.
**Option B:** While HRT may increase the risk of certain cancers, such as breast cancer, it is not the primary contraindication. HRT is not contraindicated in all cancers, but rather in those that are hormone-sensitive.
**Option C:** This option is not listed.
**Option D:** This option is not listed.

**Clinical Pearl / High-Yield Fact**
Hormone replacement therapy is not a one-size-fits-all solution, and its risks and benefits must be carefully weighed on a case-by-case basis. Patients should be thoroughly evaluated for contraindications and precautions before starting HRT.

**Correct Answer:** B. Breast cancer.